RPG Life Sciences surged 9.15% to Rs 2,275.15 after the pharmaceutical company's net profit jumped 32.01% to Rs 34.93 crore on 12.36% rise in revenue from operations to Rs 172.71 crore in Q3 FY25 over Q3 FY24.
Profit before tax (PBT) gained 31.93% to Rs 46.89 crore in Q3 FY25 from Rs 35.54 crore in Q3 FY24.
Total expenses added 7.53% YoY to Rs 129.13 crore during the quarter. Employee benefits expense stood at Rs 28.71 crore (down 14.78% YoY), and finance costs came in at Rs 0.12 (down 14.28% YoY).
On a nine-month basis, the companys consolidated net profit tumbled 11.46% to Rs 65.89 crore despite a 12.14% increase in revenue from operations to Rs 510.34 crore in 9M FY25 over 9M FY24.
RPG Life Sciences in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app